Description
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Product Unit Size | Cost | Quantity | Stock |
---|
CEP-28122 is an ALK inhibitor. It inhibits tumor growth in ALK positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroglastoma cells.
Cas No. | 1022958-60-6 |
---|---|
Purity | ≥98% |
Formula | C28H35ClN6O3 |
Formula Wt. | 539.08 |
IUPAC Name | (1S,2S,3R,4R)-3-[(5-Chloro-2-{[(7S)-1-methoxy-7-(4-morpholinyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino}-4-pyrimidinyl)amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide |
Synonym | CEP 28122, CEP28122 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Cheng M., Quail M., et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 11(3):670-79 (2012). PMID: 22203728.
RAD51 inhibitor.
Anthracenedione, DNA intercalator; Pim-1 inhibi...
NO donor.
Antipruritic.
Ca2+ ionophore.
5-HT1B/1D agonist.
Endogenous vitamin D prodrug.
GSK3 inhibitor.
HDAC inhibitor.
Triterpene aglycone originally found in Centell...
TRPM8 activator, TRPV3 blocker.
STING agonist
mGluR5 positive modulator.
STING antagonist
GABA-A antagonist.
Hydantoin derivative; RyR antagonist, L-type Ca...
Vitamin B6 derivative, antioxidant.
CRM1/XPO1 inhibitor.
Aldose reductase inhibitor.
Histamine H2 inverse agonist.